Female Health Company January 20, 2006 Form 8-K/A
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
__________________
FORM
8-K/A
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): January
20, 2006
|
THE
FEMALE HEALTH COMPANY
|
|
(Exact
name of registrant as specified in its charter)
|
|
Wisconsin
|
|
(State
or other jurisdiction of
incorporation)
|
|
1-13602
|
|
39-1144397
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer I.D. Number)
|
|
515
North State Street, Suite 2225
Chicago,
Illinois
|
|
60610
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
|
312-595-9123
|
|
(Registrant's
telephone number, including area code)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
o
Written
communications
pursuant to Rule 425 under the Securities Act
(17
CFR
230.425)
o
Soliciting
material
pursuant to Rule 14a-12 under the Exchange Act
(17
CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the
Exchange
Act (17 CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the
Exchange
Act (17 CFR 240.13e-4(c))
The
Form
8-K of The Female Health Company dated January 20, 2006, filed with the
Securities and Exchange Commission on January 24, 2006, is hereby amended by
(1)
modifying the first paragraph of Item 1.01 in its entirety as described below
and (2) revising in its entirety the following response to Item
9.01.
Section
1 - Registrant's Business and Operations
Item
1.01 Entry
into a Material Definitive Agreement
On
January 20, 2006, The Female Health Company (the "Corporation") entered into
an
Employment Agreement (the "Employment Agreement") with Mary Ann Leeper
("Dr. Leeper"), the President and Chief Operating Officer of the
Corporation, and a member of the Corporation's Board of Directors. The
Employment Agreement is effective as of May 1, 2006 (the "Effective Date").
Dr.
Leeper will continue to serve as the Corporation's President and Chief Operating
Officer until the Effective Date pursuant to the terms of her employment
agreement with the Corporation entered
into effective May 1, 1994 (the "1994 Agreement").
The
1994 Agreement will continue in effect until the Effective Date, at which time
it will terminate. A copy of the Employment Agreement is attached as
Exhibit 99.1 to this report and is incorporated herein by reference.
Section
9 - Financial Statements and Exhibits
Item
9.01 Financial
Statements and Exhibits
(d) Exhibits
The following exhibit is furnished herewith:
Exhibit 99.1 - Employment Agreement dated effective May 1, 2006 between The
Female Health Company and Mary Ann Leeper.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
THE
FEMALE HEALTH
COMPANY
Date:
February 20, 2006
BY
/s/
O.B.
Parrish
O.B.
Parrish,
Chairman and
Chief Executive Officer